Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
WSJ Online
Fri, 09/23/11 - 12:01 pm
Eprex
anemia
recalls
JNJ
Top High-Dividend Healthcare Stocks
Seeking Alpha
Thu, 09/22/11 - 02:20 pm
dividends
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
J&J Begins to Rebound from Recalls
Barron's
Wed, 09/21/11 - 11:13 pm
recalls
JNJ
More Data on Vertex's Incivek
Yahoo/Zacks.com
Tue, 09/20/11 - 11:07 am
Vertex
Incivek
hepatitis C
Merck
JNJ
Victrelis
Analysis: New drugs drive prostate cancer market
Yahoo/AP
Mon, 09/19/11 - 06:08 pm
prostate cancer
Dendreon
Exelixis
JNJ
MDV3100
Medivation
Provenge
cabozatinib
Zytiga
Tylenol Supplies Low for Flu Season
WSJ
Sun, 09/18/11 - 12:14 pm
Tylenol
JNJ
recalls
10 Hep C Stocks on Wall Street's Watch List
TheStreet.com
Thu, 09/15/11 - 11:58 am
hepatitis C
Vertex
Merck
Anadyx
Pharmasset
Gilead
Bristol-Myers Squibb
JNJ
Medivir
Achillion
Inhibitex
Indenix
The Importance Of Due Diligence (Exemplified By Johnson & Johnson)
Seeking Alpha
Thu, 09/15/11 - 09:38 am
JNJ
due diligence
J&J Pays $85M Fine Over Natrecor Marketing
Pharmalot
Wed, 09/14/11 - 07:14 pm
Scios
Natrecor
misbranding
JNJ
off-label
Boston Scientific taps J&J exec as its next CEO
Reuters
Wed, 09/14/11 - 11:12 am
JNJ
Boston Scientific
Michael Mahoney
Four Biotech Picks to Fight Hepatitis C
Barron's
Wed, 09/14/11 - 11:07 am
hepatitis C
Achillion
Pharmasset
Inhibitex
Medivir
Vertex
JNJ
6 Deeply Undervalued Biotech Companies
Seeking Alpha
Wed, 09/14/11 - 11:03 am
Amgen
Biogen Idec
Bristol-Myers Squibb
Dendreon
Gilead
GSK
Oncothyreon
JNJ
Novartis
Sanofi
UBS
Vanda
Banking on Botox no concern for Allergan CEO
Reuters
Wed, 09/14/11 - 10:51 am
Botox
Allergan
Pharma CEOs
David Pyott
JNJ
Johnson & Johnson Gets CRL on Simponi
Yahoo/Zacks.com
Wed, 09/14/11 - 10:21 am
JNJ
Simponi
Merck
psoriatic arthritis
Medivation Remains Neutral
Yahoo/Zacks.com
Tue, 09/13/11 - 10:15 am
Medivation
JNJ
Pfizer
dimebon
Alzheimer's disease
prostate cancer
MDV3100
Commonly Used Pain Pills Increase Kidney Cancer Risk in Study
Bloomberg
Mon, 09/12/11 - 05:48 pm
kidney cancer
ibuprofen
JNJ
Pfizer
Bayer
naproxen
Even if FDA approves Xarelto, Pradaxa could still gain
Fierce Pharma
Mon, 09/12/11 - 10:39 am
FDA
Xarelo
Pradaxa
bloodthinners
Bayer
JNJ
Boehringer Ingelheim
J&J’s Simponi Fails to Receive U.S. FDA Clearance for Wider Use
Bloomberg
Sat, 09/10/11 - 10:36 am
JNJ
Simponi
psoriatic arthritis
arthritis
The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
Forbes
Sat, 09/10/11 - 10:25 am
Xarelto
JNJ
anti-clotting
atrial fibrillation
FDA
Anti-Clotting Stumble For J&J/Bayer Likely to Help Pfizer/Bristol-Meyers
Seeking Alpha
Fri, 09/9/11 - 11:36 am
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Xarelto
Pages
« first
‹ previous
…
153
154
155
156
157
158
159
160
161
…
next ›
last »